Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Spruce Biosciences Inc (SPRB)

Spruce Biosciences Inc (SPRB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Spruce Biosciences Inc 611 GATEWAY BOULEVARD SUITE 740 SOUTH SAN FRANCISCO CA 94080 USA

www.sprucebiosciences.com P: 415-655-4168

Description:

Spruce Biosciences Inc. is a biopharmaceutical company. It focuses on developing and commercializing novel therapies for rare endocrine disorders. The company develops tildacerfont, an non-steroidal therapy which are in clinical stage. Spruce Biosciences Inc. is based in Daly City, California.

Key Statistics

Overview:

Market Capitalization, $K 32,902
Enterprise Value, $K -60,098
Shares Outstanding, K 41,153
Annual Sales, $ 10,090 K
Annual Net Income, $ -47,920 K
Last Quarter Sales, $ 2,890 K
Last Quarter Net Income, $ -9,950 K
EBIT, $ -51,990 K
EBITDA, $ -52,560 K
60-Month Beta 2.50
% of Insider Shareholders 9.10%
% of Institutional Shareholders 91.71%
Float, K 37,408
% Float 90.90%
Short Volume Ratio 0.32

Growth:

1-Year Return -65.43%
3-Year Return -94.76%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.23 on 03/13/24
Latest Earnings Date 05/20/24
Earnings Per Share ttm -1.25
EPS Growth vs. Prev Qtr 23.33%
EPS Growth vs. Prev Year 51.06%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

SPRB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -52.31%
Return-on-Assets % -39.77%
Profit Margin % -474.93%
Debt/Equity 0.04
Price/Sales 3.08
Price/Cash Flow N/A
Price/Book 0.40
Book Value/Share 1.88
Interest Coverage -98.83
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar